1BSL01AE — Biotika as Cashflow Statement
0.000.00%
Last trade - 00:00
- €16.80m
- €14.20m
- €11.03m
- 65
- 53
- 22
- 40
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.47 | 2.5 | 2.73 | 0.515 | -0.843 |
Depreciation | |||||
Non-Cash Items | -0.078 | -0.062 | -0.796 | -0.317 | -0.227 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.34 | -1.4 | -1.17 | -3.5 | -0.169 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.59 | 3.39 | 2.89 | -1.67 | 0.286 |
Capital Expenditures | -0.468 | -0.225 | -1.47 | -0.251 | -0.703 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.81 | 0.302 | 0.093 | -0.877 | 0.444 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.343 | 0.077 | -1.37 | -1.13 | -0.259 |
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.72 | -2.51 | -0.914 | -0.202 | -0.192 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.21 | 0.958 | 0.589 | -2.99 | -0.166 |